Johnny John - Apr 4, 2022 Form 3/A - Amendment Insider Report for DELCATH SYSTEMS, INC. (DCTH)

Role
Senior Vice President Clinical Development and Medical Affairs
Signature
/s/ Johnny John
Stock symbol
DCTH
Transactions as of
Apr 4, 2022
Transactions value $
$0
Form type
3/A - Amendment
Date filed
8/15/2022, 12:06 PM
Date Of Original Report
Apr 11, 2022
Next filing
Jan 26, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DCTH Stock Option (right to buy) Apr 4, 2022 Common Stock 38.5K $7.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares will vest and become exercisable in equal monthly installments over the 36-month period beginning on the grant date (1/36th will vest on the first day of each month during said 36-month period, with the first vesting date being March 1, 2022) for so long as the reporting person remains an employee of the issuer (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan).

Remarks:

Senior Vice President Clinical Development and Medical Affairs